Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 2697560, 11 pages
https://doi.org/10.1155/2017/2697560
Research Article

Syndrome Differentiation of IgA Nephropathy Based on Clinicopathological Parameters: A Decision Tree Model

1Renal Division, Second Clinical Medical College, Guangzhou University of Traditional Chinese Medicine, Guangzhou 510006, China
2Renal Division, Shanxi Provincial Hospital of Chinese Medicine, Xi’an 710200, China
3Renal Division, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China
4Renal Division, Peking University Third Hospital, Beijing 100191, China

Correspondence should be addressed to Chuan Zou; moc.621@888145czrotcod

Received 30 November 2016; Revised 28 February 2017; Accepted 14 March 2017; Published 26 March 2017

Academic Editor: Fabio Firenzuoli

Copyright © 2017 Yanghui Gu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. J. Wyatt and B. A. Julian, “IgA nephropathy,” The New England Journal of Medicine, vol. 368, no. 25, pp. 2402–2414, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. G. D'Amico, “Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome,” Seminars in Nephrology, vol. 24, no. 3, pp. 179–196, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. L.-S. Li and Z.-H. Liu, “Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies,” Kidney International, vol. 66, no. 3, pp. 920–923, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Simon, M.-P. Ramee, R. Boulahrouz et al., “Epidemiologic data of primary glomerular diseases in western France,” Kidney International, vol. 66, no. 3, pp. 905–908, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. S. V. Jargin, “Renal biopsy research in the former soviet union: prevention of a negligent custom,” ISRN Nephrology, vol. 2013, Article ID 980859, 5 pages, 2013. View at Publisher · View at Google Scholar
  6. K. Kiryluk, Y. Li, S. Sanna-Cherchi et al., “Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis,” PLoS Genetics, vol. 8, no. 6, Article ID e1002765, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. F.-D. Zhou, M.-H. Zhao, W.-Z. Zou, G. Liu, and H. Wang, “The changing spectrum of primary glomerular diseases within 15 years: a survey of 3331 patients in a single Chinese centre,” Nephrology Dialysis Transplantation, vol. 24, no. 3, pp. 870–876, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. Kidney Disease: Improving Global Outcomes Glomerulonephritis Work Group, “KDIGO clinical practice guideline for glomerulonephritis,” Kidney International Supplements, vol. 2, no. 2, pp. 139–274, 2012. View at Google Scholar
  9. A. Francis, Y. Cho, and D. W. Johnson, “Honey in the prevention and treatment of infection in the CKD population: a narrative review,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 261425, 8 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Wang, J. Zhang, M. Guo, X. Lian, M. Sun, and L. Guo, “The efficacy of Shen shuaining capsule on chronic kidney disease: a systematic review and meta-analysis,” Evidence-Based Complementary and Alternative Medicine, vol. 2016, Article ID 7515413, 11 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Nie, “TCM differential treatment of IgA nephrosis,” Journal of Traditional Chinese Medicine, vol. 25, no. 1, pp. 37–41, 2005. View at Google Scholar · View at Scopus
  12. Y. Yuwen, N.-N. Shi, L.-Y. Wang, Y.-M. Xie, X.-J. Han, and A.-P. Lu, “Development of clinical practice guidelines in 11 common diseases with Chinese medicine interventions in China,” Chinese Journal of Integrative Medicine, vol. 18, no. 2, pp. 112–119, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. P.-C. Shen and L.-Q. He, “Effect of ‘gubentongluo formula’ on the IgA class switch recombination of B lymohocytes in Peyer's patches in mice with IgA nephropathy,” Sichuan Da Xue Xue Bao Yi Xue Ban, vol. 47, no. 3, pp. 337–341, 2016. View at Google Scholar · View at Scopus
  14. P. Shen, J. Shen, C. Sun, X. Yang, and L. He, “A system biology approach to understanding the molecular mechanisms of Gubentongluo decoction acting on IgA Nephropathy,” BMC Complementary and Alternative Medicine, vol. 16, no. 1, article 312, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. Y. Hu, Y. P. Chen, and P. Zha, “Analysis of the treatment with traditional Chinese medicine in chronic glomerulonephritis based on histopathologic type,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 12, no. 8, pp. 455–457, 1992. View at Google Scholar · View at Scopus
  16. M. Liu, C. Zhang, Q. Zha et al., “Attitudes to personalised versus standardised practice in traditional Chinese medicine: a national cross-sectional survey of practitioners in China,” The Lancet, vol. 388, supplement 1, p. S59, 2016. View at Publisher · View at Google Scholar
  17. J.-L. Tang, B.-Y. Liu, and K.-W. Ma, “Traditional Chinese medicine,” The Lancet, vol. 372, no. 9654, pp. 1938–1940, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. X.-M. Chen, “Play superior role of integrative medicine to improve clinical efficacy of IgA nephropathy,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 27, no. 6, pp. 555–556, 2007. View at Google Scholar · View at Scopus
  19. T. Ying, S. Pei-cheng, Z. Wen-jun, and H. Li-qun Shuguang, “Correlativity between Chinese Medical Syndromes and Clinical Prognosis of Iga Nephropathy,” Shanghai Journal of Traditional Chinese Medicine, vol. 44, no. 5, pp. 27–30, 2010. View at Google Scholar
  20. S. Jing and M. Hongzhen, “The relationship between renal pathological classifications and TCM syndromes of IgA nephropathy,” Journal of Jiangxi University of TCM, vol. 21, no. 3, 2009. View at Google Scholar
  21. J.-Z. Wang, P. Liu, C.-Y. He et al., “Analysis on TCM syndromes and pathological grading of 488 patients with IgA nephropathy,” Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine, vol. 15, no. 2, 2015. View at Google Scholar
  22. M. Honezhen, L. He, H. Chen, and B. Lu, “Analysis on laboratory indices and pathological characteristics of 123 IgA nephropathy cases with different TCM syndrome,” Journal of Traditional Chinese Medicine, vol. 52, no. 17, pp. 1483–1485, 2011. View at Google Scholar
  23. A. Holzinger, Data Mining with Decision Trees: Theory and Applications, 2015.
  24. J. R. Quinlan, “Induction of decision trees,” Machine Learning, vol. 1, no. 1, pp. 81–106, 1986. View at Google Scholar
  25. D. C. Cattran, R. Coppo, H. T. Cook et al., “The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification,” Kidney International, vol. 76, no. 5, pp. 534–545, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. X. Y. Zheng, Guiding Principle of Clinical Research on New Drugs of Traditional Chinese Medicine (Trial), Chinese Medical Science and Technology Press, 2002.
  27. CKD Work Group, “KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease,” Kidney International Supplements, vol. 3, no. 1, pp. 1–150, 2013. View at Google Scholar
  28. P.-H. Hou, J. Fang, and S. Li, “Distribution features of Chinese medicine syndrome types in IgA nephropathy patients complicated with hypertension and analysis of its correlated factors,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 31, no. 8, pp. 1080–1084, 2011. View at Google Scholar · View at Scopus
  29. J.-J. Li, X.-M. Chen, and R.-B. Wei, “Potential of renal pathology on refining syndrome typing of chinese medicine in IgA nephropathy,” Chinese Journal of Integrative Medicine, vol. 19, no. 2, pp. 92–97, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. X.-M. Chen, Y.-P. Chen, and P. Li, “A multi-centeric epidemiological survey on TCM syndrome in 1016 patients with IgA nephropathy and analysis of its relevant factors,” Chinese Journal of Integrated Traditional & Western Medicine, vol. 26, no. 3, pp. 197–201, 2006. View at Google Scholar · View at Scopus
  31. X.-M. Chen, Y.-P. Chen, and Y.-P. Chen, “Multicenter prospective study on relationship of TCM syndrome type and renal pathology in 286 patients with IgA nephropathy,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 24, no. 2, pp. 101–105, 2004. View at Google Scholar · View at Scopus
  32. X.-M. Chen, Y.-P. Chen, and Z.-L. Zhou, “Prospective, multi-centered, randomized and controlled trial on effect of Shenle Capsule in treating patients with IgA nephropathy of Fei-Pi qi-deficiency syndrome,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 26, no. 12, pp. 1061–1065, 2006. View at Google Scholar · View at Scopus
  33. X.-M. Chen, Y.-P. Chen, and J. Chen, “Multicentered, randomized, controlled clinical trial on patients with IgA nephropathy of Qi-yin deficiency syndrome type,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 27, no. 2, pp. 101–105, 2007. View at Google Scholar · View at Scopus
  34. Y. Wang, H. Chen, and C. Zhu, “Study on syndrome-manifestation of traditional Chinese medicine in 1148 patients with IgA nephropathy,” Chinese Journal of Integrated Traditional, 2009. View at Google Scholar
  35. F. Lin, Z. Zhang, S.-F. Lin, J.-S. Zeng, and Y.-F. Gan, “Study of TCM clinical records based on LSA and LDA SHTDT model,” Experimental and Therapeutic Medicine, vol. 12, no. 1, pp. 288–296, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. W. Dai, X. Liu, Z. Zhang et al., “A two-level model for the analysis of syndrome of acute ischemic stroke: from diagnostic model to molecular mechanism,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 293010, 15 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. K.-F. Chung, W.-F. Yeung, F. Y.-Y. Ho et al., “Comparison of scoring methods for the Brief Insomnia Questionnaire in a general population sample,” Journal of Psychosomatic Research, vol. 78, no. 1, pp. 34–38, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. W.-F. Yeung, K.-F. Chung, N. L.-W. Zhang et al., “Identification of Chinese medicine syndromes in persistent insomnia associated with major depressive disorder: a latent tree analysis,” Chinese Medicine, vol. 11, no. 1, pp. 1–11, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. N. N. Jin, “Study of traditional Chinese medicine syndrome factors of dysfunctional uterine bleeding based on cluster analysis and factor analysis,” China Journal of Chinese Materia Medica, vol. 33, no. 13, pp. 1622–1625, 2008. View at Google Scholar
  40. J. Dai, J. Fang, S. Sun et al., “ZHENG-omics application in ZHENG classification and treatment: Chinese personalized medicine,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 235969, 9 pages, 2013. View at Publisher · View at Google Scholar
  41. L. Breiman, Classification and Regression Trees, Wadsworth International Group, Belmont, Calif, USA, 1984.
  42. T. M. Therneau and E. J. Atkinson, “An introduction to recursive partitioning using the RPART routine,” Tech. Rep. 61, Mayo Foundation, Rochester, NY, USA, 1997. View at Google Scholar